Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20111
20131
20141
20151
20162
20174
20184
20193
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
QED Therapeutics, a BridgeBio company3
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
PTC Therapeutics2
Spark Therapeutics, Inc.2
Vertex Pharmaceuticals Incorporated2
Alexion Pharmaceuticals, Inc.1
Novo Nordisk A/S1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn23
Musculoskeletal Diseases7
Blood Coagulation Disorders6
Blood Coagulation Disorders, Inherited6
Coagulation Protein Disorders6
Genetic Diseases, X-Linked6
Hematologic Diseases6
Hemophilia A6
Hemorrhagic Disorders6
Achondroplasia5

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.